Long Natco PharmaImproving Fundamentals
Tailwinds for Pharma
Higher highs and higher lows
CMP 853.55
SL 700
Target 1200
NATCOPHARM trade ideas
NATCO PHARMANATCO PHARMA Making CUP & HANDLE Pattern Beautifully & Looking at Depth of Cup we Can See Target is Really Promising
Inside candle break outNatco pharma monthly insder candle break out seen with SL 800 for 1030 to 1k possible
Natco Pharma Long TermDisclaimer - This is not a Stock recommendation.
Investments in securities are subject to market risk. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason.
It's an educational post for analyzing, learning & discussing general and generic information related to stocks, investments, and strategies.
Natco Pharma - Cup and Handle formationCup and Handle formation can be seen on monthly time frame. Stock has retraced from the resistance level.
natco pharma cup and handle- trend line area 936.10
- multiple time rejection area
- previous S1 766 and current market rate 782 is good area to consider
For the dreamers, the magic pill of Natco may be seen in 2024When things arent going your way, bend the chart and make the technicals prove your thesis!
The monthly chart of Natco shows that its been travelling more or less within a parallel channel and is yet to complete an Impulse wave which began in 2002 and is most likely in the start of wave 5 (specifically completing wave 1 and undergoing corrective wave 2 of bigger degree wave 5)
The good news? whenever the correction ends, a bull run may occur in Natco and the way things are stacked for the company, addressing the usfda problems in Kothur looks to be the trigger now as it has already demonstrated ability to earn super normal profits thorugh its policy of complex generics... how much lower the price will go is anyones guess....how high it can reach...well, there was not enough display space in my laptop to fit in the extension of parallel channel and show the max limit...lol!
P.S.
Wave 2 correction may be more severe if an Import Alert is issued to the Kothur plant .. most retail shareholders including myself may not be able to hold on if and when this occurs so tread knowingly
Natco, always 2 steps forward and 1 step back Just when the profits of years of perseverance have begun rolling into the bank for Natco Pharma, the minority investors are in a spot of bother due to twin negative news of legal action in US pertaining to gRevlimid and the USFDA Form 483 with 8 observations during the Kothur plant inspection earlier in the month.
The legal action is of lesser concern as the company has a marketing partner in US who most likely has to bear the legal costs, and there are well established laws regarding patents in the country. Kothur plant is only one of the 2 USFDA approved manufacturing plants for Natco and this plant is capable of manufacturing cytotoxic orals and injectibles. It is imperative for the company to get a clean chit in its follow up from the USFDA. The management of Natco has an impeccable track record and Kothur is their older USFDA approved plant which has been subject to audits from last many years.
Meanwhile the share price has taken a beating after the most impressive quarterly performance in the companys history.
In the long run price is a slave to earnings and with that adage one can take a position and look forward to the completion of an INHS in the making which may coincide with stellar Q2 numbers as guided by the mgmt in the Q1 concall.
By the time Q4 results get declared we are looking at net profit of +1000 crores (management guidance) and this has a 50% probability of being bettered in the following year.
NATCO PHARMA FORMING INVERSE HEAD AND SHOULDERThe stock follows a trend giving great positional returns for short term moreover it can face
and certain drawback till the 841 levels in order to complete the pattern but after it nothing can stop it from breaching 992 and 1045 levels
Narto pharma ready for breakout in rounding bottomNarto pharma ready for breakout in rounding bottom cmp 882 on 17 sep 23
Natco pharmaboolis sector.
Monthly rsi above 55.
positive RS.
debt free company.
keep long term investing.
NATCO PHARMA restricted UpsideNATCO PHARMA restricted Upside
520 Low (Mar-23)to 916 (Aug-2023) = 76% high
200 EMA = 650, Currently at 10 DMA support level of 840
Already Broke last 2 daily lows
Current Support at 835 and if brook then 785 / 700 levels
upside only after 917 break.
Natco Pharma: Trading near 2 years upper range Natco Pharma is looking good for further breakout of 2 year consolidation. Keep on radar
NATCOPHARMNATCOPHARM:- Stock has given strong breakout, if stock comes back for retesting then you can plan something
Hello traders,
As always, simple and neat charts so everyone can understand and not make it too complicated.
rest details mentioned in the chart.
will be posting more such ideas like this. Until that, like share and follow :)
check my other ideas to get to know about all the successful trades based on price action.
Thanks,
Ajay.
keep learning and keep earning.
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that 90% of the stocks give most of the movement in just 1-2 days and the rest of the time they either consolidate or fall
Trendline Breakout in NATCOPHARM
BUY TODAY SELL TOMORROW for 5%
Natco going up steadilyAfter almost 8 months of consolidation decent upmove in last 1 month.
EMA cross over done. Cup and handle in making
Wait till it breaks resistance at 770 then sky is the limit. Should reach 1000 in 3 months if not early
Natco pharma breakout from flag pattern Natco pharma has broken out from a flag pattern on the daily timeframe with the next resistance at 770. Technically this is a buy signal with the stop below the day's low.
Natco Pharma: Trading near breakout levelNatco Pharma is trading near breakout level. Keep on radar for closing above 780. Stock is changing trend after 2 years. Seems consolidation has been done and stock is getting ready for breakout. Company has announced excellent results for last quarter.
NATCO, the underperforming quality pharma stockInvestors are wary of Natco Pharma as it has failed to perform in earlier years when it was tipped to be the one. However, the fundamentals are painting a different picture, with a sublime Q4 performance, USFDA approval of its Vizag unit, drug launch approvals in US, subsidiaries in Canada and Mexico doing well, the seguey into agrochemicals stabilizing....negligible debt, competed a 2% buyback in May 2023 wherein the promoters did not participate.. it has a modest PE valuation as on date compared to its 5 year history... stock has already broken out of its downtrend... a bit of consolidation is alway good before further direction emerges.. keeping a stoploss of 609 I am taking position in this counter
Natco pharma good to go for a 8% rideNatco pharma good to go for a 8% ride
it made a bottom after a long consolidation.
we can see positive upside move in this stock
Natcopharma looks bullish Natcopharma bullish above 685+
SL 650
TGT 760+
Disclaimer - This is not a call and tips it's only for educational purpose
Natco Pharma: Offering highly favorable risk reward set upNatco Pharma is looking good on weekly time frame. Seems chart is going to complete rounding bottom pattern. Keep on radar.
